Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1991-4-8
|
pubmed:abstractText |
Twenty pediatric patients (ages, between 8 months and 8 years) received a single oral dose of cefprozil at levels of 15 and 30 mg/kg of body weight. Cefprozil consists of cis (BMY-28100) and trans (BMY-28167) isomers in an approximately 90:10 ratio. Six plasma samples were collected from each pediatric patient and assayed for drug concentrations. As measured by a microbiological assay, peak concentrations of 11.16 and 15.93 micrograms of cefprozil per ml occurred at 1 h for patients who received the 15- and 30-mg/kg doses, respectively. The respective mean half-lives of cefprozil were 1.77 and 2.14 h, and the respective mean areas under the curve were 28.05 and 45.28 micrograms.h/ml for patients who received the 15- and 30-mg/kg doses. When measured by a high-pressure liquid chromatography method, peak concentrations of 12.09 and 18.04 micrograms of the cis isomer per ml were obtained at 1 h, with mean half-lives of 1.63 and 2.06 h and mean areas under the curve of 30.48 and 49.34 micrograms.h/ml in patients who received the 15- and 30-mg/kg doses, respectively. For the trans isomer, peak concentrations of 1.16 and 1.63 micrograms/ml occurred at 1 h, respectively, with mean half-lives of 1.61 and 1.65 h and mean areas under the curve of 2.89 and 4.34 micrograms.h/ml in patients who received the 15- and 30-mg/kg doses, respectively.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2073105-2327766,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2073105-2393281,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2073105-2393283,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2073105-3105449,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2073105-7252794
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0066-4804
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2152-5
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:2073105-Administration, Oral,
pubmed-meshheading:2073105-Cephalosporins,
pubmed-meshheading:2073105-Child,
pubmed-meshheading:2073105-Child, Preschool,
pubmed-meshheading:2073105-Chromatography, High Pressure Liquid,
pubmed-meshheading:2073105-Female,
pubmed-meshheading:2073105-Half-Life,
pubmed-meshheading:2073105-Humans,
pubmed-meshheading:2073105-Infant,
pubmed-meshheading:2073105-Intestinal Absorption,
pubmed-meshheading:2073105-Male,
pubmed-meshheading:2073105-Microbial Sensitivity Tests
|
pubmed:year |
1990
|
pubmed:articleTitle |
Pharmacokinetics of cefprozil in infants and children.
|
pubmed:affiliation |
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|